Gene clue to vaccine against leukaemia
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A vaccine capable of preventing childhood leukaemia could soon be a possibility, scientists said yesterday, after discovering an important genetic clue to the disease.
A vaccine capable of preventing childhood leukaemia could soon be a possibility, scientists said yesterday, after discovering an important genetic clue to the disease.
Children born with a certain genetic abnormality linked to leukaemia could be given a jab to prevent them from going on to develop the disease.
About 450 British children are diagnosed with leukaemia a year. They have a "leukaemic gene" called TEL-AML1. The genetic abnormality develops in the womb but it takes an average of three or four years for the child to develop leukaemia.
Scientists from the Institute of Cancer Research have now found that about 1 per cent of newborn babies have the gene - 100 times the incidence of leukaemia itself. This holds out the possibility that the disease could be prevented. Scientists said a second "event" after birth, such as an abnormal response to an infection, could trigger the leukaemia.
Professor Mel Greaves, a researcher, said: "Some form of vaccination in infancy might well prevent leukaemia occurring. That is our goal."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments